Management options for cavernous sinus meningiomas

Journal of Neuro-Oncology

Volumn 92, Issue 3 SPEC. ISS., 2009, Pages 307-316

  Walsh, Michael T ^a   Couldwell, William T ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Cavernous sinus; Meningiomas; Radiosurgery; Skull base; Surgery

Indexed keywords

BRAIN SURGERY; CAROTID ARTERY INJURY; CAVERNOUS SINUS; CLINICAL FEATURE; COGNITIVE DEFECT; CONSERVATIVE TREATMENT; CRANIAL NERVE PARALYSIS; CRANIAL NEUROPATHY; DIPLOPIA; EXOPHTHALMOS; EYE MOVEMENT DISORDER; FACE PAIN; GAMMA KNIFE RADIOSURGERY; HEADACHE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; RADIATION DOSE FRACTIONATION; RADIATION NECROSIS; REVIEW; SEIZURE; STEREOTACTIC RADIOSURGERY; TUMOR CALCINOSIS; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR REGRESSION; TUMOR VOLUME; VISUAL IMPAIRMENT;

CAVERNOUS SINUS; COMBINED MODALITY THERAPY; DECOMPRESSION, SURGICAL; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; NEUROSURGICAL PROCEDURES; RADIOSURGERY; RADIOTHERAPY;

EID: 65249167593     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9824-5     Document Type: Review

References (63)

1. Frotscher B (1910) Zur kasuistik der duraendotheliome. Arch Psychiatr Nervenkr 47:196-199. doi: 10.1007/BF02322942
2. Cushing H, Eisenhardt L (1938) Meningiomas: Their classification, regional behavior, life history and surgical end results. Charles C Thomas, Springfield
3. Parkinson D (1965) A surgical approach to the cavernous portion of the carotid artery. Anatomical studies and case report. J Neurosurg 23:474-483
4. Dolenc V (1979) Microsurgical removal of large sphenoidal bone meningiomas. Acta Neurochir Suppl (Wien) 28:391-396
5. Dolenc V (1989) Anatomy and surgery of the cavernous sinus. Springer-Verlag, New York
6. Kotapka MJ, Kalia KK, Martinez AJ, Sekhar LN (1994) Infiltration of the carotid artery by cavernous sinus meningioma. J Neurosurg 81:252-255
7. Larson JJ, van Loveren HR, Balko MG, Tew JM Jr (1995) Evidence of meningioma infiltration into cranial nerves: Clinical implications for cavernous sinus meningiomas. J Neurosurg 83:596-599
8. Sen C, Hague K (1997) Meningiomas involving the cavernous sinus: histological factors affecting the degree of resection. J Neurosurg 87:535-543
9. Olivero WC, Lister JR, Elwood PW (1995) The natural history and growth rate of asymptomatic meningiomas: A review of 60 patients. J Neurosurg 83:222-224
10. Go RS, Taylor BV, Kimmel DW (1998) The natural history of asymptomatic meningiomas in Olmsted County, Minnesota. Neurology 51:1718-1720
11. Yano S, Kuratsu J (2006) Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg 105:538-543. doi: 10.3171/jns.2006.105.4.538
12. Yoneoka Y, Fujii Y, Tanaka R (2000) Growth of incidental meningiomas. Acta Neurochir (Wien) 142:507-511. doi: 10.1007/s007010050463
13. Herscovici Z, Rappaport Z, Sulkes J, Danaila L, Rubin G (2004) Natural history of conservatively treated meningiomas. Neurology 63:1133-1134
14. Nakamura M, Roser F, Michel J, Jacobs C, Samii M (2003) The natural history of incidental meningiomas. Neurosurgery 53:62-70 (discussion 70-71)
15. Kuratsu J, Kochi M, Ushio Y (2000) Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 92:766-770
16. Niiro M, Yatsushiro K, Nakamura K, Kawahara Y, Kuratsu J (2000) Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry 68:25-28. doi: 10.1136/jnnp.68.1.25
17. Sekhar LN, Sen CN, Jho HD, Janecka IP (1989) Surgical treatment of intracavernous neoplasms: A four-year experience. Neurosurgery 24:18-30. doi: 10.1097/00006123-198901000-00004
18. Ebner FH, Bornemann A, Wilhelm H, Ernemann U, Honegger J (2008) Tuberculum sellae meningioma symptomatic during pregnancy: pathophysiological considerations. Acta Neurochir (Wien) 150:189-193 (discussion 193)
19. Goldberg M, Rappaport ZH (1987) Neurosurgical, obstetric and endocrine aspects of meningioma during pregnancy. Isr J Med Sci 23:825-828
20. Couldwell WT (2006) Asymptomatic meningiomas. J Neurosurg 105:536-537 (discussion 537)
21. Hirsch WL, Sekhar LN, Lanzino G, Pomonis S, Sen CN (1993) Meningiomas involving the cavernous sinus: Value of imaging for predicting surgical complications. AJR Am J Roentgenol 160:1083-1088
22. De Jesus O, Sekhar LN, Parikh HK, Wright DC, Wagner DP (1996) Long-term follow-up of patients with meningiomas involving the cavernous sinus: recurrence, progression, and quality of life. Neurosurgery 39:915-919 (discussion 919-920)
23. DeMonte F, Smith HK, Al-Mefty O (1994) Outcome of aggressive removal of cavernous sinus meningiomas. J Neurosurg 81:245-251
24. Abdel-Aziz KM, Froelich SC, Dagnew E, Jean W, Breneman JC, Zuccarello M, van Loveren HR, Tew JM Jr (2004) Large sphenoid wing meningiomas involving the cavernous sinus: Conservative surgical strategies for better functional outcomes. Neurosurgery 54:1375-1383 (discussion 1383-1384)
25. Sekhar LN, Patel S, Cusimano M, Wright DC, Sen CN, Bank WO (1996) Surgical treatment of meningiomas involving the cavernous sinus: evolving ideas based on a ten year experience. Acta Neurochir Suppl (Wien) 65:58-62
26. Knosp E, Perneczky A, Koos WT, Fries G, Matula C (1996) Meningiomas of the space of the cavernous sinus. Neurosurgery 38:434-442 (discussion 442-444)
27. Sindou M, Wydh E, Jouanneau E, Nebbal M, Lieutaud T (2007) Long-term follow-up of meningiomas of the cavernous sinus after surgical treatment alone. J Neurosurg 107:937-944. doi: 10.3171/JNS-07/11/0937
28. Chang SD, Adler JR Jr, Martin DP (1998) LINAC radiosurgery for cavernous sinus meningiomas. Stereotact Funct Neurosurg 71:43-50. doi: 10.1159/ 000029647
29. Iwai Y, Yamanaka K, Ishiguro T (2003) Gamma knife radiosurgery for the treatment of cavernous sinus meningiomas. Neurosurgery 52:517-524 (discussion 523-524)
30. Lee JY, Niranjan A, McInerney J, Kondziolka D, Flickinger JC, Lunsford LD (2002) Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J Neurosurg 97:65-72
31. Liscak R, Simonova G, Vymazal J, Janouskova L, Vladyka V (1999) Gamma knife radiosurgery of meningiomas in the cavernous sinus region. Acta Neurochir (Wien) 141:473-480. doi: 10.1007/s007010050327
32. Roche PH, Regis J, Dufour H, Fournier HD, Delsanti C, Pellet W, Grisoli F, Peragut JC (2000) Gamma knife radiosurgery in the management of cavernous sinus meningiomas. J Neurosurg 93(suppl 3):68-73
33. Shin M, Kurita H, Sasaki T, Kawamoto S, Tago M, Kawahara N, Morita A, Ueki K, Kirino T (2001) Analysis of treatment outcome after stereotactic radiosurgery for cavernous sinus meningiomas. J Neurosurg 95:435-439
34. Spiegelmann R, Nissim O, Menhel J, Alezra D, Pfeffer MR (2002) Linear accelerator radiosurgery for meningiomas in and around the cavernous sinus. Neurosurgery 51:1373-1379 (discussion 1379-1380)
35. Abeloos L, Levivier M, Devriendt D, Massager N (2007) Internal carotid occlusion following gamma knife radiosurgery for cavernous sinus meningioma. Stereotact Funct Neurosurg 85:303-306. doi: 10.1159/000107365
36. Tishler RB, Loeffler JS, Lunsford LD, Duma C, Alexander EIII, Kooy HM, Flickinger JC (1993) Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys 27:215-221
37. Leber KA, Bergloff J, Pendl G (1998) Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 88:43-50
38. Couldwell WT, Cole CD, Al-Mefty O (2007) Patterns of skull base meningioma progression after failed radiosurgery. J Neurosurg 106:30-35. doi: 10.3171/jns.2007.106.1.30
39. Linskey ME, Davis SA, Ratanatharathorn V (2005) Relative roles of microsurgery and stereotactic radiosurgery for the treatment of patients with cranial meningiomas: A single-surgeon 4-year integrated experience with both modalities. J Neurosurg 102(suppl):59-70
40. Couldwell WT, Kan P, Liu JK, Apfelbaum RI (2006) Decompression of cavernous sinus meningioma for preservation and improvement of cranial nerve function. Technical note. J Neurosurg 105:148-152. doi: 10.3171/ jns.2006.105.1.148
41. Pamir MN, Kilic T, Bayrakli F, Peker S (2005) Changing treatment strategy of cavernous sinus meningiomas: Experience of a single institution. Surg Neurol 64(suppl 2):S58-S66. doi: 10.1016/ j.surneu.2005.07.053
42. Maruyama K, Shin M, Kurita H, Kawahara N, Morita A, Kirino T (2004) Proposed treatment strategy for cavernous sinus meningiomas: A prospective study. Neurosurgery 55:1068-1075. doi: 10.1227/ 01.NEU.0000140839.47922.5A
43. van Loveren HR, Keller JT, El-Kalliny M, Scodary DJ, Tew JM Jr (1991) The Dolenc technique for cavernous sinus exploration (cadaveric prosection). Technical note. J Neurosurg 74:837-844
44. Jensen RL, Wendland MM, Chern SS, Shrieve DC (2008) Novalis intensity-modulated radiosurgery: Methods for pretreatment planning. Neurosurgery 62:A2-A9 (discussion A9-10)
45. Loven D, Hardoff R, Sever ZB, Steinmetz AP, Gornish M, Rappaport ZH, Fenig E, Ram Z, Sulkes A (2004) Non-resectable slow-growing meningiomas treated by hydroxyurea. J Neurooncol 67:221-226. doi: 10.1023/ B:NEON.0000021827.85754.8e
46. Newton HB, Scott SR, Volpi C (2004) Hydroxyurea chemotherapy for meningiomas: Enlarged cohort with extended follow-up. Br J Neurosurg 18:495-499
47. Newton HB, Slivka MA, Stevens C (2000) Hydroxyurea chemotherapy for unresectable or residual meningioma. J Neurooncol 49:165-170. doi: 10.1023/A:1026770624783
48. Weston GJ, Martin AJ, Mufti GJ, Strong AJ, Gleeson MJ (2006) Hydroxyurea treatment of meningiomas: A pilot study. Skull Base 16:157-160. doi: 10.1055/s-2006-949518
49. Fuentes S, Chinot O, Dufour H, Paz-Paredes A, Metellus P, Barrie-Attarian M, Grisoli F (2004) Hydroxyurea treatment for unresectable meningioma. Neurochirurgie 50:461-467. doi: 10.1016/ S0028-3770(04)98326-9
50. Grunberg SM, Weiss MH, Spitz IM, Ahmadi J, Sadun A, Russell CA, Lucci L, Stevenson LL (1991) Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg 74:861-866
51. Mason WP, Gentili F, Macdonald DR, Hariharan S, Cruz CR, Abrey LE (2002) Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma. J Neurosurg 97:341-346
52. Schrell UM, Rittig MG, Anders M, Kiesewetter F, Marschalek R, Koch UH, Fahlbusch R (1997) Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway. J Neurosurg 86:845-852
53. Ragel BT, Couldwell WT, Wurster RD, Jensen RL (2007) Chronic suppressive therapy with calcium channel antagonists for refractory meningiomas. Neurosurg Focus 23(4):E10. doi: 10.3171/FOC-07/10/E10
54. Ragel BT, Gillespie DL, Kushnir V, Polevaya N, Kelly D, Jensen RL (2006) Calcium channel antagonists augment hydroxyurea- and RU486-induced inhibition of meningioma growth in vivo and in vitro. Neurosurgery 59:1109-1120 (discussion 1120-1121)
55. Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT (2005) Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. J Neurosurg 103:508-517
56. Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT (2007) Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer 109:588-597. doi: 10.1002/cncr.22441
57. Kaba SE, DeMonte F, Bruner JM, Kyritsis AP, Jaeckle KA, Levin V, Yung WK (1997) The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B. Neurosurgery 40:271-275. doi: 10.1097/ 00006123-199702000-00007
58. Koper JW, Zwarthoff EC, Hagemeijer A, Braakman R, Avezaat CJ, Bergstrom M, Lamberts SW (1991) Inhibition of the growth of cultured human meningioma cells by recombinant interferon-alpha. Eur J Cancer 27:416-419
59. Wober-Bingol C, Wober C, Marosi C, Prayer D (1995) Interferon-alfa-2b for meningioma. Lancet 345:331. doi: 10.1016/S0140-6736(95)90326-7
60. Arena S, Barbieri F, Thellung S, Pirani P, Corsaro A, Villa V, Dadati P, Dorcaratto A, Lapertosa G, Ravetti JL, Spaziante R, Schettini G, Florio T (2004) Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity. J Neurooncol 66:155-166. doi: 10.1023/B:NEON.0000013498.19981.55
61. Chamberlain MC, Glantz MJ, Fadul CE (2007) Recurrent meningioma: Salvage therapy with long-acting somatostatin analogue. Neurology 69:969-973. doi: 10.1212/01.wnl.0000271382.62776.b7
62. Schulz S, Pauli SU, Handel M, Dietzmann K, Firsching R, Hollt V (2000) Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clin Cancer Res 6:1865-1874
63. Johnson MD, Sade B, Milano MT, Lee JH, Toms SA (2008) New prospects for management and treatment of inoperable and recurrent skull base meningiomas. J Neurooncol 86:109-122. doi: 10.1007/s11060-007-9434-z